Post by Gautam Kumar Das

🚨 The US FDA called India for help this week. Not with a warning letter. Not with an inspection notice. With a request. A critical cancer drug shortage hit the US market and the FDA's first call went to Indian pharma companies. This fact remind you everything, where India stands in global pharma right now!! 👉 In this week's Pharma Growth Blueprint (Issue #43), I break down: ✅ The ifosfamide shortage crisis and what it signals for Indian pharma's global positioning ✅ Sun Pharma's $28.7M acquisition and the BD role behind it ✅ AbbVie's $10.9B immunology bet + GSK's $14B deal spree in 2026 ✅ The Nifty Pharma rally decoded, sentiment or fundamentals? If you are a pharma founder, BD head, CDMO leader, or consultant , this one is worth 5 minutes of your Sunday. 👇